brequinar has been researched along with tacrolimus in 17 studies
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 16 (94.12) | 18.2507 |
| 2000's | 0 (0.00) | 29.6817 |
| 2010's | 0 (0.00) | 24.3611 |
| 2020's | 1 (5.88) | 2.80 |
| Authors | Studies |
|---|---|
| Dranchak, PK; Huang, R; Inglese, J; Lamy, L; Oliphant, E; Queme, B; Tao, D; Wang, Y; Xia, M | 1 |
| Lemster, B; Starzl, TE; Strednak, J; Thomson, AW; Todo, S; Wang, SC; Woo, J | 1 |
| Thomson, AW | 1 |
| Morris, RE | 1 |
| Ito, T; Kamiike, W; Matsuda, H; Miyata, M; Nakata, S; Nozaki, S; Shirakura, R; Stepkowski, SM; Uchikoshi, F; Yamamoto, S | 1 |
| Cramer, DV; Jaffee, BD; Jordan, S; Makowka, L; Moudgil, A; Toyoda, M; Wang, SJ | 1 |
| Surdacka, E; Surdacki, A; Sułowicz, W | 1 |
| Kahan, BD | 1 |
| Demetris, AJ; Miyazawa, H; Murase, N; Nakamura, K; Starzl, TE; Tanabe, M; Valdivia, LA | 1 |
| Duquesnoy, RJ; Fung, JJ; Starzl, TE; Todo, S; Venkataramanan, R; Yao, GZ; Zeevi, A | 1 |
| Cramer, D; Demetris, AJ; Makowka, L; Murase, N; Starzl, TE; Tanabe, M; Valdivia, L | 1 |
| Bumgardner, GL; Roberts, JP | 1 |
| Morris, RE; Murphy, MP | 1 |
| Ericzon, BG; Gannedahl, G; Groth, CG; Ohlman, S | 1 |
| Antoniou, E; D'Silva, M; DeRoover, A; Howie, A; McMaster, P; Nishimura, Y | 1 |
| Halloran, PF | 1 |
| Antoniou, EA; Chondros, K; D'Silva, M; Deroover, A; Howie, AJ; McMaster, P | 1 |
7 review(s) available for brequinar and tacrolimus
| Article | Year |
|---|---|
The spectrum of action of new immunosuppressive drugs.
Topics: Animals; Biphenyl Compounds; Cyclosporine; Guanidines; Humans; Immunosuppressive Agents; Polyenes; Sirolimus; Tacrolimus | 1992 |
Immunopharmacology of new xenobiotic immunosuppressive molecules.
Topics: Animals; Biphenyl Compounds; Cyclosporine; Graft Rejection; Guanidines; Humans; Immunosuppressive Agents; Mycophenolic Acid; Polyenes; Ribonucleosides; Sirolimus; Tacrolimus; Xenobiotics | 1992 |
[New immunosuppressive drugs in transplantation].
Topics: Biphenyl Compounds; Cyclosporine; Guanidines; Humans; Immunosuppressive Agents; Mycophenolic Acid; Polyenes; Ribonucleosides; Sirolimus; Spiro Compounds; Tacrolimus; Transplantation Immunology | 1994 |
New immunosuppressive drugs--pharmacologic approaches to alter immunoregulation.
Topics: Animals; Antimetabolites; Azathioprine; Biphenyl Compounds; Cell Differentiation; Cyclosporine; Guanidines; Humans; Immunosuppressive Agents; Isoxazoles; Leflunomide; Lymphocytes; Lymphokines; Oligonucleotides, Antisense; Polyenes; Receptors, Cytokine; Ribonucleosides; Signal Transduction; Sirolimus; Tacrolimus | 1994 |
New immunosuppressive agents.
Topics: Alprostadil; Animals; Antibodies, Monoclonal; Biphenyl Compounds; Child; Disease Models, Animal; Dogs; Guanidines; Humans; Immunosuppressive Agents; Liver Transplantation; Mycophenolic Acid; Polyenes; Rats; Sirolimus; Tacrolimus | 1993 |
New immunosuppressive drugs in transplantation.
Topics: Biphenyl Compounds; Cyclosporins; Guanidines; Humans; Immunosuppressive Agents; Kidney; Mycophenolic Acid; Polyenes; Sirolimus; T-Lymphocytes; Tacrolimus; Transplantation Immunology | 1993 |
Molecular mechanisms of new immunosuppressants.
Topics: Amino Acid Isomerases; B-Lymphocytes; Biphenyl Compounds; Calcineurin; Calmodulin-Binding Proteins; Carrier Proteins; Cyclosporine; Enzyme Inhibitors; Humans; Immunosuppressive Agents; IMP Dehydrogenase; Isoxazoles; Leflunomide; Mycophenolic Acid; Oxidoreductases; Peptidylprolyl Isomerase; Phosphoprotein Phosphatases; Polyenes; Purines; Pyrimidines; Receptors, Cytokine; Ribonucleosides; Signal Transduction; Sirolimus; T-Lymphocytes; Tacrolimus | 1996 |
10 other study(ies) available for brequinar and tacrolimus
| Article | Year |
|---|---|
In vivo quantitative high-throughput screening for drug discovery and comparative toxicology.
Topics: Animals; Caenorhabditis elegans; Drug Discovery; High-Throughput Screening Assays; Humans; Proteomics; Small Molecule Libraries | 2023 |
Cytokine gene expression in murine lymphocytes activated in the presence of FK 506, bredinin, mycophenolic acid, or brequinar sodium.
Topics: Animals; B-Lymphocytes; Biphenyl Compounds; Cells, Cultured; Dose-Response Relationship, Drug; Gene Expression Regulation; Immunosuppressive Agents; Interleukin-10; Interleukin-2; Lymphocyte Activation; Mice; Mycophenolic Acid; Polymerase Chain Reaction; Ribonucleosides; Tacrolimus | 1992 |
Effect of brequinar sodium on accelerated cardiac allograft rejection in presensitized recipients.
Topics: Animals; Antibody-Dependent Cell Cytotoxicity; Biphenyl Compounds; Cytotoxicity, Immunologic; Dose-Response Relationship, Drug; Graft Rejection; Graft Survival; Heart Transplantation; Immunization; Immunosuppressive Agents; Lymphocyte Culture Test, Mixed; Male; Rats; Rats, Inbred BUF; Rats, Inbred Lew; Skin Transplantation; T-Lymphocytes; Tacrolimus; Transplantation, Homologous | 1994 |
Inhibition of in vitro immunoglobulin production by a novel immunosuppressive drug brequinar sodium.
Topics: Adult; Biphenyl Compounds; Cyclosporine; Dose-Response Relationship, Drug; Dose-Response Relationship, Immunologic; Humans; Immunoglobulin A; Immunoglobulin G; Immunoglobulin M; Immunosuppressive Agents; Leukocytes, Mononuclear; Lymphocyte Activation; Pokeweed Mitogens; Tacrolimus | 1994 |
Effect of FK 506 and antiproliferative agents for heart and liver xenotransplantation from hamster to rat.
Topics: Animals; Antibodies; Antineoplastic Agents; Azathioprine; Biphenyl Compounds; Cricetinae; Cyclophosphamide; Graft Survival; Guanidines; Heart Transplantation; Immunosuppressive Agents; Liver Transplantation; Male; Mesocricetus; Methotrexate; Mycophenolic Acid; Rats; Rats, Inbred Lew; Ribonucleosides; Tacrolimus; Transplantation, Heterologous | 1993 |
Comparative in vitro studies on the immunosuppressive effects of purine and pyrimidine synthesis inhibitors.
Topics: Aspartic Acid; Biphenyl Compounds; Calcimycin; Cells, Cultured; Cyclosporine; Humans; Immunosuppressive Agents; Interleukin-2; Lymphocyte Activation; Lymphocytes; Mycophenolic Acid; Phosphonoacetic Acid; Ribonucleosides; T-Lymphocytes; Tacrolimus; Tetradecanoylphorbol Acetate; Tumor Cells, Cultured | 1993 |
Hamster-to-rat heart and liver xenotransplantation with FK506 plus antiproliferative drugs.
Topics: Animals; Antibody Formation; Antilymphocyte Serum; Biphenyl Compounds; Cricetinae; Cyclophosphamide; Drug Synergism; Drug Therapy, Combination; Fluorescent Antibody Technique; Follow-Up Studies; Graft Rejection; Graft Survival; Heart Transplantation; Immunoglobulin A; Immunoglobulin M; Immunosuppressive Agents; Liver Transplantation; Male; Mesocricetus; Mycophenolic Acid; Rats; Splenectomy; Tacrolimus; Transplantation, Heterologous | 1993 |
Brequinar sodium effectively and potently suppresses allograft rejection in a heterotopic mouse heart transplant model.
Topics: Animals; Biphenyl Compounds; Cyclosporine; Dose-Response Relationship, Drug; Drug Administration Schedule; Graft Rejection; Heart Transplantation; Immunosuppressive Agents; Mice; Mice, Inbred BALB C; Mice, Inbred C3H; Models, Biological; Polyenes; Sirolimus; Tacrolimus; Transplantation, Homologous | 1993 |
Immunosuppressive effect of brequinar on rat cardiac allograft survival in combination with leflunomide or FK 506.
Topics: Animals; Biphenyl Compounds; Drug Therapy, Combination; Graft Rejection; Graft Survival; Heart Transplantation; Histocompatibility Testing; Immunosuppressive Agents; Isoxazoles; Leflunomide; Rats; Rats, Inbred Lew; Rats, Inbred Strains; Spleen; Tacrolimus; Transplantation, Homologous | 1996 |
Immunosuppressive effect of combination schedules of brequinar with leflunomide or tacrolimus on rat cardiac allotransplantation.
Topics: Animals; Biphenyl Compounds; Drug Evaluation, Preclinical; Drug Therapy, Combination; Graft Rejection; Heart Transplantation; Immunosuppression Therapy; Immunosuppressive Agents; Isoxazoles; Leflunomide; Male; Postoperative Period; Rats; Rats, Inbred Lew; Tacrolimus; Transplantation, Homologous; Transplantation, Isogeneic | 1999 |